NEW YORK, March 6 - Orchid BioSciences on Wednesday said it earned approximately $2.5 million after money-management firm Robertson Stephens exercised its over-allotment option to purchase an additional 1 million shares of the company.
Registering provides access to this and other free content.
Already have an account?Login Now.
Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.
Bill Gates tells the Telegraph that bioterrorism is a serious risk.
The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.
CBS News reports that the White House Science Fair is to continue under President Donald Trump.